AcelRx Pharmaceuticals, Inc.
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for th…
Drug Manufacturers - Specialty & Generic
US, Hayward [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
AcelRx Pharmaceuticals, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDAcelRx Pharmaceuticals, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of AcelRx Pharmaceuticals, Inc..
If you want to see a demo, head over to the financial segments of AAPL